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RESEARCH ARTICLE

Cold-inducible RNA-binding protein activates splenic
T cells during sepsis in a TLR4-dependent manner
Alexandra C Bolognese1,2, Archna Sharma3, Weng-Lang Yang1,2,3, Jeffrey Nicastro2, Gene F Coppa2
and Ping Wang1,2,3
Cold-inducible RNA-binding protein (CIRP) is a novel inﬂammatory mediator that stimulates the release of
proinﬂammatory cytokines from macrophages in sepsis. Given the immune dysregulation that characterizes sepsis,
the effect of CIRP on other immune cells is an area of increasing interest that has not yet been studied. In the
present study, we hypothesized that extracellular CIRP promotes activation of T lymphocytes in the spleen during
sepsis. We observed that mice subjected to sepsis by cecal ligation and puncture showed signiﬁcantly higher
expression of the early activation markers CD69 and CD25 at 20 h on CD4+ splenic T cells, and signiﬁcantly higher
CD69 expression on CD8+ splenic T cells compared with sham-operated controls. Furthermore, at 20 h after
receiving intravenous injection of recombinant murine CIRP (rmCIRP, 5 mg/kg body weight (BW)) or PBS (vehicle),
those mice receiving rmCIRP showed signiﬁcantly increased expression of CD69 and CD25 on both CD4+ and CD8+
splenic T cells. This effect, however, was not seen in TLR4-deﬁcient mice after rmCIRP injection. In addition,
treatment with CIRP predisposed CD4+ T cells to a Th1 hyperinﬂammatory response proﬁle, and inﬂuenced CD8+
T cells toward a cytotoxic proﬁle. Taken together, our ﬁndings indicate that CIRP is a proinﬂammatory mediator that
plays an important role in T-cell dysregulation during sepsis in a TLR4-dependent manner.
Cellular & Molecular Immunology (2018) 15, 38–47; doi:10.1038/cmi.2016.43; published online 29 August 2016
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INTRODUCTION
After several decades of evolving deﬁnitions attempting to
effectively deﬁne sepsis, the most recent consensus guidelines
characterize it as a dysregulated host response to infection that
results in life-threatening organ dysfunction.1 It is a serious
clinical entity that can ultimately lead to shock and death, with
recent global mortality estimates as high as 5.3 million lives per
year.2–4 In the United States, sepsis is a major public health
problem accounting for over 1 million hospitalizations and
over $24 billion in treatment costs annually.5,6
The immune response to sepsis is multifactorial, and is often
described as consisting of two stages, the timing of which is
likely complex and overlapping. The ﬁrst component is a state
of hyperinﬂammation, also referred to as the ‘cytokine storm’.7
This is typically thought to predominate early on in the course
of the disorder and is generally attributed to the actions of the
innate immune system, including macrophages, neutrophils
1

and natural killer (NK) cells, as well as a subset of the
T lymphocyte population, natural killer T (NKT) cells. The
second component of the immune response is a state of
immunosuppression in which patients are particularly susceptible to secondary infection, a major cause of morbidity and
mortality in sepsis.7,8 This aspect of the immune response can
largely be attributed to dysfunction of the adaptive immune
system, including B and T lymphocytes.
One component of the immune response to sepsis
is inﬂammation caused by pathogen-associated molecular
patterns (PAMPs), which are elements of invading organisms
that trigger cytokine release on detection by pathogen
recognition receptors (PRRs) present on immune cells.
A second component of the immune response to sepsis is
caused by damage-associated molecular patterns (DAMPs).
DAMPs are endogenous molecules that, under normal conditions, remain hidden from recognition by the immune system.
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However, in times of cellular stress (for example, hypoxia,
ischemia, mechanical injury), these molecules are released and
trigger inﬂammation.9
Cold-inducible RNA-binding protein (CIRP) is a 172-amino
acid nuclear protein that has recently been identiﬁed as a
DAMP.10 It is a cold-shock protein, originally found to impair
cell growth in the setting of hypothermia.11 CIRP can bind to
RNAs and modulate them at the post-transcriptional level,12
and is involved in regulating diverse cellular physiological
processes, including cell growth, senescence and apoptosis.13
More recently it has also been found at increased levels in
humans with sepsis and hemorrhagic shock. In addition, in
animal models neutralization with anti-CIRP antibody prolonged survival and attenuated organ injury in sepsis and
hemorrhagic shock.10 Furthermore, in vitro work demonstrated
that CIRP is able to stimulate the release of the proinﬂammatory cytokines TNF-α and HMGB1 from macrophages.10 Given
the immune dysregulation that characterizes sepsis, and the
role of CIRP in sepsis and shock, the interaction of CIRP with
other cells of the immune system is an area of particular
interest. Speciﬁcally, its effect on T lymphocytes is worth
exploring, because T cells have a special role in the immune
response, being key components of the adaptive system while
also contributing to the innate immune response.
Many aspects of T-cell function can be studied, including
antigen presentation and recognition, T-cell activation, proliferation, differentiation and effector functions. In the present
study, we examined T-cell activation by looking at the
expression of two surface molecules known to be upregulated
on activation: CD69 and CD25. CD69 is well-established as an
early activation antigen of immune cells.14,15 It has been used
as a marker of T-cell activation in septic animals and humans,
as well as in children with pneumonia.16–18 CD25 is also
known as the alpha subunit of the interleukin 2 (IL-2) receptor,
and IL-2 is a cytokine implicated in lymphocyte proliferation.
CD25 is upregulated slightly later in the course of T-cell
activation, and has also been used as a marker of T-cell
activation in animals and humans.15,18,19
In this study, we hypothesized that extracellular CIRP would
have an important role in the activation of T cells and
contribute to the immune dysregulation seen in sepsis. In
order to examine this, we subjected mice to polymicrobial
sepsis by cecal ligation and puncture (CLP), followed by ﬂow
cytometric analysis of splenic T lymphocytes. We then looked
at changes in T-cell proﬁles in mice injected with recombinant
murine CIRP (rmCIRP). We further explored the role of tolllike receptor 4 (TLR4) in this setting by injecting TLR4deﬁcient (Tlr4−/−) mice with rmCIRP. Lastly, we explored the
downstream effects of CIRP on T-cell effector functions.
MATERIALS AND METHODS
Experimental animals
Adult male C57BL/6 mice (20-25 g) were purchased from
Charles River Laboratories (Wilmington, MA, USA). On
acquisition, mice were allowed to acclimate to the environment
in our facility for a period of 7 days. Tlr4−/− mice were donated

by the lab of Dr Kevin Tracey at the Feinstein Institute for
Medical Research (Manhasset, NY, USA). All mice were housed
in a temperature-controlled room with a 12-h light-dark cycle,
fed a standard laboratory diet, and allowed water ad libitum.
All experiments were performed in accordance with the
guidelines for the use of experimental animals by NIH
(Bethesda, MD, USA) and were approved by the Institutional
Animal Care and Use Committee (IACUC) of the Feinstein
Institute for Medical Research. For all in vivo experiments,
anesthesia was induced and maintained using inhaled
isoﬂurane.
Polymicrobial sepsis model
Sepsis was induced by CLP, as previously described by
Wisnoski et al.20 with minor modiﬁcations. Mice were randomly assigned to undergo CLP or sham operation. After
anesthesia induction, mice were placed supine and their
abdomens shaved and prepped with betadine solution.
A midline incision was performed through the skin and
peritoneum. The cecum was identiﬁed and extracorporalized.
In sham-operated controls, the cecum was then returned to the
abdomen and the incision was closed with non-absorbable
suture. In CLP animals, 50% of the cecum was ligated with
non-absorbable suture. The distal aspect of the cecum was then
punctured twice with a 22-gauge needle, and a small amount of
feces was extruded. The cecum was then returned to the
abdominal cavity and the abdomen was closed with nonabsorbable suture. In all cases animals received 0.5 ml of
normal saline resuscitation subcutaneously, were observed to
recover from anesthesia, and were then returned to their cages.
At 20 h after operation, all mice were killed by CO2 asphyxiation and organs were collected for processing.
Puriﬁcation of rmCIRP and removal of lipopolysaccharide
Transformed E. coli carrying the rat His-CIRP expression
plasmid were inoculated in Luria–Bertani medium containing
kanamycin overnight. They were subsequently induced with
1 mM isopropyl β-D-1-thiogalactopyranoside for an additional
6 h. Following this, the bacteria were collected by centrifugation
and washed once with 20 mM Tris–HCl, pH 7.9. The pellet was
resuspended in 20 mM Tris–HCl, pH 7.9, 500 mM NaCl and
5 mM imidazole. It was then lysed by sonication at 4 °C. The
soluble extract was clariﬁed by centrifugation at 20 000g for 1 h
at 4 °C. Clear lysate was then loaded onto a nickelnitrilotriacetic acid column (Novagen, Madison, WI, USA).
Bound protein was washed with 20 mM Tris–HCl, pH 7.9,
500 mM NaCl and 100 mM imidazole, and was eluted in the
same buffer supplemented with 1 M imidazole. All proteins
were dialyzed with phosphate-buffered solution (PBS) and
stored at − 80 °C before use. Triton X-114 (Sigma-Aldrich, St
Louis, MO, USA) was added to the puriﬁed rmCIRP protein at
a ﬁnal concentration of 5%. It was then rotated for 15 min at
room temperature to ensure homogeneity. It was subsequently
centrifuged at 14 000g for 12 min, and the upper aqueous phase
(lipopolysaccharide (LPS)-free rmCIRP) was removed.
The level of LPS was measured by a limulus amebocyte lysate
Cellular & Molecular Immunology
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(LAL) assay (Cambrex, East Rutherford, NJ, USA), and was
o10 pg LPS/μg rmCIRP.
Administration of rmCIRP
Mice were randomly assigned to receive 5 mg/kg body weight
rmCIRP or equivalent volume PBS (vehicle). After induction of
anesthesia, mice were placed supine and the area over the right
jugular vein was shaved and prepped with betadine. An incision
was made and dissection carried out to the level of the jugular
vein. This was then isolated, and rmCIRP or PBS injected. The
vein was then ligated with non-absorbable suture and the
incision closed. Animals were observed to recover from
anesthesia and were then returned to their cages. At 20 h after
injection, all mice were killed by CO2 asphyxiation and organs
were collected for processing.
Western blot analysis
Spleen samples (100 mg) were lysed and homogenized in 250 μl
lysis buffer (10 mM Tris-buffered saline pH 7.5, 1% Triton
X-100, 1 mM ethylenediaminetetraacetic acid, 1 mM ethylene
glycol tetraacetic acid) containing a protease inhibitor cocktail
(Roche Diagnostics, Indianapolis, IN, USA) by sonication.
After 30-min incubation at 4 °C, samples were centrifuged at
13,200 r.p.m. for 15 min. Supernatant was then collected, and
sample protein concentration was measured using the Pierce
BCA Protein Assay Kit (Thermo Scientiﬁc, Somerset, NJ, USA).
Once protein concentration was determined, 50 μg samples
were separated on 4–12% Bis–Tris gels and transferred to
nitrocellulose membranes. Membranes were then incubated
with primary antibody against CIRP or β-actin (SantaCruz
Biotechnologies, Santa Cruz, CA, USA). Protein bands were
detected by immunoﬂuorescence using species-speciﬁc ﬂuorescent secondary antibodies and the LI-COR Odyssey Fc
Imager (LI-COR, Lincoln, NE, USA). Band intensity was
measured using the NIH Image J densitometric software
program (Bethesda, MD, USA).
Lymphocyte preparation from spleen and T-cell puriﬁcation
Spleens were disrupted and homogenized by crushing and
ﬁltering through a sterile 70 μm nylon ﬁlter in complete RPMI
medium (with 10% FBS, 1% Penn-Strep, 10 mM HEPES, 2 mM
L-glutamine and 50 μM β-mercaptoethanol). Erythrocytes were
eliminated using ACK Lysing Buffer (Quality Biological,
Gaithersburg, MD, USA) and the cells were then washed and
resuspended in complete RPMI medium. CD4+ and CD8+
T cells were puriﬁed from splenic lymphocytes by immunomagnetic negative selection using EasySep CD4+ T cell and
CD8+ T Cell Isolation Kits (STEMCELL Technologies, Vancouver, BC, Canada) per manufacturer instructions.
Flow cytometry
Cells were stained with the following ﬂuorescent antibodies in
ﬂow cytometry buffer (PBS, 2% fetal bovine serum, 0.1%
sodium azide): APC-CD8, PerCP/Cy5.5-CD4, PE-CD69, PE/
Cy7-CD25 (Biolegend, San Diego, CA, USA) and analyzed
using a BD LSRFortessa ﬂow cytometer (BD Biosciences, San
Cellular & Molecular Immunology

Jose, CA, USA). Flow cytometry data was analyzed using
FlowJo 7.6.5 software (FlowJo LLC, Ashland, OR, USA).
CD4+ T cell Th1/Th2 PCR array and CD8+ T cell real-time
polymerase chain reaction (qPCR)
Puriﬁed CD4+ and CD8+ T cells from the spleens of healthy
mice were stimulated (in complete RPMI media on α-CD3/αCD28-coated 24-well plates) with or without rmCIRP
(1 μg/ml) for 20 h at 37 °C. Cells were then collected and total
RNA was extracted using TRIzol reagent (Invitrogren, Carlsbad, CA, USA).
Total CD4+ T-cell RNA (0.5 μg) then underwent reverse
transcription using the RT2 First Strand Kit (QIAGEN,
Germantown, MD, USA) per manufacturer instructions. qPCR
was then carried out using the RT2 Proﬁler PCR Array for
Mouse Th1 & Th2 Responses (QIAGEN) per manufacturer
instructions. An ABI 7300 real-time PCR machine (Applied
Biosystems, Foster City, CA, USA) was used for ampliﬁcation
using absolute quantiﬁcation under the thermal proﬁle of 95 °C
for 10 min, followed by 40 cycles of 95 °C for 15 s and 60 °C
for 1 min. Data was then analyzed using the manufacturer’s
web-based data analysis suite (QIAGEN). A fold regulation
threshold of ± 2 with a P-value of 0.05 was used for detecting
changes in gene expression between groups.
Total CD8+ T-cell RNA (2 μg) underwent reverse transcription using murine leukemia virus reverse transcriptase (Applied
Biosystems). PCR was carried out in a 25 μl ﬁnal volume
containing 0.5 μl each of forward and reverse primers, 5 μl
cDNA, 6.5 μl H2O and 12.5 μl Power SYBR Green PCR Master
Mix (Applied Biosystems). An ABI 7300 real-time PCR
machine was used for ampliﬁcation under the thermal proﬁle
of 50 °C for 2 min and 95 °C for 10 min, followed by 45 cycles
of 95 °C for 15 sec and 60 °C for 1 min. Mouse β-actin mRNA
levels were used for normalization. Relative expression of
mRNA was calculated by the 2 − ΔΔCt method, and results are
expressed as fold change in comparison to control group. The
sequences for the primers used in this study are as follows:
mouse regulated on activation, normal T cell expressed and
secreted (RANTES) 5′-GCCCACGTCAAGGAGTATTT-3′
(forward) and 5′-AGCAAGCAATGACAGGGAAG-3′ (reverse);
mouse granzyme B 5′-ACCCAAAGACCAAACGTGCT-3′ (forward) and 5′-AGCAGGATCCATGTTGCTTC-3′ (reverse);
mouse interferon gamma (IFN-γ) 5′-GGCTTTGCAGCTCT
TCCTC-3′ (forward) and 5′-CCAGTTCCTCCAGATATCCAA-3′
(reverse); and mouse β-actin, 5′-CGTGAAAAGATGACC
CAGATCA-3′ (forward) and 5′-TGGTACGACCAGAGGCAT
ACAG-3′ (reverse).
Statistical analysis
All data are expressed as mean ± s.e.m. and compared by twotailed Student’s t-test for pair comparisons. Differences in
values are considered signiﬁcant if Po0.05.
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RESULTS
Sepsis induces activation of splenic CD4+ and CD8+ T cells
We ﬁrst examined the activation status of T cells in the spleen,
a lymphoid organ and source of abundant T lymphocytes, in
sepsis. At 20 h after sepsis induction by CLP, spleens were
collected and processed to isolate lymphocytes for ﬂow
cytometric analysis. After acquisition, total cells were gated for
the lymphocyte population based on forward and side scatter
(FSC-A and SCC-A) characteristics; from this, the population
staining positively for PerCP/Cy5.5-CD4 was gated (Figure 1a).
This CD4+ T-cell population was subsequently gated on
PE-CD69-positive and PE/Cy7-CD25-positive populations
(Figure 1a). Sepsis resulted in a signiﬁcant increase in the
expression of activation markers CD69 and CD25 on CD4+
T cells compared to sham-operated controls (Figure 1b). This
was true for the percentages of CD69+ (11.3 vs 18.9%,
Po0.05) and CD25+ (12.9 vs 16.5%, Po0.05) cells, as well
as for the expression levels of CD69 and CD25 per cell,
indicated by the mean ﬂuorescence intensity (MFI; CD69 MFI:
110 vs 147; CD25 MFI: 104 vs 126; Po0.05). For the CD8+
T cells, total splenocytes were again ﬁrst gated for the
lymphocyte population based on FSC-A and SCC-A characteristics (Figure 2a); from this, the population staining positively
for APC-CD8 was gated (Figure 2a). This CD8+ population
was subsequently gated on PE-CD69-positive and PE/Cy7CD25-positive populations (Figure 2a). Sepsis resulted in a

signiﬁcant increase in the expression of CD69 on CD8+ T cells
compared to sham-operated controls (Figure 2b). This was true
for the percentages of CD69+ cells (4.8 vs 10.7%, Po0.05), as
well as for the expression level of CD69 per cell, indicated by
the MFI (98 vs 121, Po0.05).
CIRP protein levels in the spleen are increased after CLP
After identifying the activation of splenic T cells in sepsis, we
sought to determine the protein expression of CIRP in septic
mice by western blotting. CIRP protein levels in the spleen
were increased 2-, 3- and 4-fold compared with sham-operated
controls at 5, 10 and 20 h after CLP, respectively (Figure 3).
This result demonstrates an association between CIRP elevation
and T-cell activation in sepsis.
Administration of rmCIRP induces activation of splenic
CD4+ and CD8+ T cells in mice
To further examine the effect of CIRP on the activation of
T cells, rmCIRP was injected intravenously into healthy mice.
Twenty hours after injection, spleens were collected and
processed to isolate lymphocytes for ﬂow cytometric analysis.
rmCIRP administration resulted in signiﬁcant increases in the
expression of activation markers CD69 and CD25 on both
CD4+ (Figure 4a) and CD8+ (Figure 4b) T cells compared
to PBS administration. This was demonstrated by the
percentages of CD69+ (CD4+CD69+: 13.8 vs 28.2%, CD8+

Figure 1 Activation of CD4+ splenic T cells after CLP. Mice underwent CLP or sham operation; spleens were collected 20 h later and
processed to isolate lymphocytes. (a) A representative sample showing ﬂow cytometry gating strategy. Total splenocytes were gated for the
live lymphocyte population based on FSC and SSC characteristics. Lymphocytes were subsequently gated for the PerCP/Cy5.5-CD4-positive
cell population and further gated into those staining positively for PE-CD69 and PE/Cy7-CD25. (b) Flow cytometric analysis of surface
CD69 and CD25 expression on the gated splenic CD4+ T cells. Percentages of CD69+ and CD25+ cells and mean ﬂuorescence intensity
(MFI) of CD69 and CD25 expression are shown. Data expressed as mean ± s.e.m. (n = 5 per group) and compared by Student’s t-test.
*Po0.05 vs Sham. CLP, cecal ligation and puncture; FSC, forward scatter; SSC, side scatter.
Cellular & Molecular Immunology
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CD69+: 5.4 vs 19.1%, Po0.05) and CD25+ (CD4+CD25+: 10.1
vs 14.8%, CD8+CD25+: 1.1 vs 1.4, Po0.05) cells, as well as by
the expression levels of CD69 and CD25 per cell indicated by
the MFI (CD69 MFI on CD4+T: 150 vs 285; CD69 MFI on
CD8+T: 114 vs 174; CD25 MFI on CD4+T: 119 vs 162; CD25
MFI on CD8T: 41.7 vs 48.0; Po0.05).

responses by PCR array. Those CD4+ T cells treated with
rmCIRP showed signiﬁcant upregulation of seven genes
involved in T-helper cell immune responses (Figure 6). Two
of these genes were CD4+ T-cell markers, one was a Th2
marker, and the remaining four were Th1 markers and related

TLR4 is required for CIRP-induced T-cell activation
It has been demonstrated that CIRP can directly bind to
TLR4.10 Therefore, we further determined whether TLR4 was
involved in CIRP-induced T-cell activation. Tlr4−/−mice were
injected intravenously with rmCIRP. Twenty hours after
injection, spleens were collected and processed to isolate
lymphocytes for ﬂow cytometric analysis. In Tlr4−/−mice,
rmCIRP administration did not result in any increase in
expression of CD69 or CD25 on CD4+ T cells compared to
PBS administration (Figure 5), indicating that CIRP-induced
T-cell activation is mediated in a TLR4-dependent manner.
rmCIRP induces a hyperinﬂammatory Th1 response proﬁle
in CD4+ T cells
Activation is an initial step in the cascade of T-cell functions
following antigen presentation and recognition. We next
examined the downstream effects of T-cell activation induced
by CIRP. We focused on the differentiation of CD4+ T cells to
Th1 and Th2 helper cells, and measured the change in
expression levels of 84 genes involved in Th1 and Th2

Figure 3 Protein levels of CIRP in the spleen after CLP. Mice
underwent CLP or sham operation; spleens were collected at 5, 10
and 20 h after CLP and CIRP protein levels were determined by
western blot. A representative blot is shown along with a graph
representing densitometry analysis. Data expressed as mean ± s.e.m.
(n = 2 mice in sham group and 3 mice per CLP group). *Po0.05
vs Sham by Student’s t-test. CLP, cecal ligation and puncture;
CIRP, cold-inducible RNA-binding protein.

Figure 2 Activation of CD8+ splenic T cells after CLP. Mice underwent CLP or sham operation; spleens were collected 20 h later and
processed to isolate lymphocytes. (a) A representative sample showing ﬂow cytometry gating strategy. Total splenocytes were gated for the
live lymphocyte population based on FSC and SSC characteristics. Lymphocytes were subsequently gated for the APC-CD8-positive cell
population and further gated into those staining positively for PE-CD69 and PE/Cy7-CD25. (b) Flow cytometric analysis of surface CD69
and CD25 expression on the gated splenic CD8+ T cells. Percentages of CD69+ and CD25+ cells and MFI of CD69 and CD25 expression
are shown. Data expressed as mean ± s.e.m. (n = 5 per group) and compared by Student’s t-test. *Po0.05 vs Sham. CLP, cecal ligation
and puncture; FSC, forward scatter; SSC, side scatter.
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Figure 4 Activation of CD4+ and CD8+ splenic T cells by rmCIRP. rmCIRP (5 mg/kg BW) or PBS was intravenously injected in mice;
spleens were collected 20 h later and processed to isolate lymphocytes. Flow cytometric analysis of surface CD69 and CD25 expression on
the gated splenic CD4+ T cells (a) and CD8+ T cells (b) from rmCIRP- and PBS-injected mice. Percentages of CD69+ and CD25+ cells and
mean ﬂuorescence intensity (MFI) of CD69 and CD25 expression are shown. Data expressed as mean ± s.e.m. (n = 4–5 per group) and
compared by Student’s t-test. *Po0.05 vs PBS. BW, body weight; rmCIRP, recombinant murine CIRP; PBS, phosphate-buffered solution.

genes. Speciﬁcally, the Th1-associated genes interferon-γ (Ifng),
interleukin 12 receptor beta 2 (Il12rb2), T-bet (Tbx21) and
colony stimulating factor 2 (Csf2) were increased 7-, 5-, 4- and
2-fold, respectively, compared to control (Po0.05). Suppressor
of cytokine signaling 3 (Socs3) and interleukin 6 (Il6), two
CD4+ T-cell markers, were increased 3- and 4-fold, respectively
(Po0.05). The only Th2-associated gene was interleukin
13 (Il13), which was increased 4-fold in CIRP-treated cells
(Po0.05). No genes were downregulated. A complete list of
examined genes and their fold regulation after CIRP treatment
can be found in Supplementary Table 1.
rmCIRP induces a cytotoxic response proﬁle in CD8+ T cells
We also examined the response of CD8+ T cells to rmCIRP at
the transcriptional level. Granzyme B (Gzmb), a serine protease
contained in the granules of cytotoxic lymphocytes, was
upregulated 5-fold in rmCIRP-treated cells compared with
untreated cells (Po0.05, Figure 7a). Two additional genes
important for cytotoxic T-cell function, RANTES (Ccl5) and
IFN-γ (Ifng), were upregulated 8- and 7-fold, respectively,
although these increases did not reach statistical signiﬁcance
(Figures 7b and c). These ﬁndings suggest that CIRP induces a
cytotoxic proﬁle to promote the inﬂammatory response in
sepsis.
DISCUSSION
We have shown an increase in levels of CIRP protein in the
spleen in an animal model of sepsis. This is consistent with
previous research demonstrating elevated CIRP protein levels

in the liver and serum of rats at 20 h after CLP.10 Likewise,
previous studies have shown that CIRP is released into the
serum in both animal models of sepsis and ICU patients with
sepsis.10,21 The spleen was our primary organ of interest for
this investigation because it is the largest secondary lymphoid
organ, containing ~ 5% of the body’s lymphocytes.22
In addition, in male C57BL/6 mice, just over 20% of
splenocytes are comprised of CD4+ and CD8+ T
lymphocytes.23
We have demonstrated an upregulation of the early lymphocyte activation markers CD69 and CD25 on CD4+ T cells,
and shown that CD8+ T cells show upregulation of CD69, but
not CD25, at the relatively early time point of 20 h after sepsis
onset. Previous studies have shown increased expression of
CD69 on stimulated human T cells in vitro and in septic ICU
patients, as well as in various models of animal sepsis.15–17,19
For example, in murine E. coli sepsis, those mice that received
intravenous inoculation with E. coli demonstrated an increase
in CD69 expression on both CD4+ and CD8+ T cells within
24 h, compared to PBS-injected mice.16 Interestingly, recent
work has identiﬁed CD69’s importance as a regulator of
immune responses, beyond its role in T-cell activation.24 In
multiple chronic inﬂammatory conditions, including asthma,25
arthritis26 and inﬂammatory bowel disease,27 the absence of
CD69 resulted in exacerbation of disease severity. Thus, CD69’s
upregulation in sepsis may have an important part in regulating
the inﬂammatory response, in addition to serving as a marker
for lymphocyte activation. CD25 has additionally been used as
a marker of T-cell activation in septic models, usually
Cellular & Molecular Immunology
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Figure 5 Mediation of splenic CD4+ T-cell activation by TLR4.
rmCIRP (5 mg/kg BW) or PBS was intravenously injected in Tlr4−/−
mice; spleens were collected 20 h later and processed to isolate
lymphocytes. Flow cytometric analysis of surface CD69 and CD25
expression on the gated splenic CD4+ T cells from PBS- and
rmCIRP-injected Tlr4−/− mice. Percentages of CD69+ (a) and CD25+
(c) cells and MFI of CD69 (b) and CD25 (d) expression on gated
CD4+ T cells are shown. Data expressed as mean ± s.e.m. (n = 4–5
per group) and compared by Student’s t-test. BW, body weight;
rmCIRP, recombinant murine CIRP; PBS, phosphate-buffered
solution; MFI, mean ﬂuorescence intensity; NS, no signiﬁcance.

increasing later on in the course of sepsis.19 Our ﬁnding of an
increased frequency of CD4+CD25+ lymphocytes in the spleen
is consistent with previous study in murine sepsis.28
We have shown that the administration of rmCIRP in mice
induces CD69 and CD25 upregulation in both CD4+ and
CD8+ T cells. This extends our understanding of CIRP’s role in
the immune response to sepsis as a molecule capable of
initiating adaptive immune responses in addition to its
documented role in stimulating cytokine release from
macrophages.10 This is consistent with similar observations of
other DAMPs in the immune response to critical illness. Highmobility group protein B1 (HMGB1), for example, was
discovered to be released from macrophages after treatment
with endotoxin, TNF-α or IL-1,29 and further that it can
activate neutrophils and increase their expression of proinﬂammatory cytokines.30 Later study showed an association of
HMGB1 with immunosuppression and T-cell dysfunction in
the context of severe burn injury.31 These ﬁndings highlight the
importance of DAMPs in both proinﬂammatory stress
responses and post-injury T-cell dysfunction. Our current
ﬁndings expand on this to include induction of T-cell activation as an important adaptive function of DAMPs. However,
unlike after rmCIRP injection, we have not observed an
Cellular & Molecular Immunology

Figure 6 Clustergram of genes upregulated in CD4+ T cells after
treatment with rmCIRP. Puriﬁed splenic CD4+ T cells (1 × 106/ml/
well) were treated with rmCIRP (1 μg/ml) or PBS for 20 h during
plate-bound anti-CD3/CD28 (1 μg/ml each) stimulation. An 84-gene
PCR array was used to examine Th1 vs Th2 response proﬁles for
CD4+ T cells. A clustergram featuring the seven genes that were
signiﬁcantly upregulated is shown (n = 3 per group, Po0.05 by
Student’s t-test). Of these, four are Th1-related genes (Ifng, Csf2,
Tbx21 and Il12rb2), two are CD4 T-cell markers (Socs3 and Il6),
and one is a Th2-related cytokine (Il13). No genes were
downregulated. rmCIRP, recombinant murine CIRP; PCR,
polymerase chain reaction.

increase in the CD8+CD25+ T-cell population in septic mice
induced by CLP. In this polymicrobial sepsis model, many
antigens and inﬂammatory mediators are released and elevated
in the peritoneal cavity and circulation, which may counteract
CIRP’s effect on CD25 expression in splenic CD8+ T cells.
Detailed kinetic analysis of the timing of CD25 expression and
elevation of inﬂammatory mediators after CLP may further
facilitate the understanding of such differential responses.
T-cell anergy has been well-documented in the late stages of
sepsis;32–34 given the recent work elucidating CD69’s immunoregulatory function discussed above, this molecule may serve
an important link between T-cell activation in the initial
response to sepsis and later T-cell anergy. CIRP’s ability to
upregulate CD69 in the absence of sepsis lends further support
to CIRP’s importance in immunoregulation. In addition, we
have shown that CIRP induces an increase in CD4+CD25+ T
lymphocytes, or regulatory T cells (Treg). This is consistent with
previous ﬁndings in sepsis, in which the Treg population has
been documented to increase, and this increase has been found
to be in part responsible for the depletion of other T-cell
populations in the late stages of sepsis.20,35–37 This highlights yet
another way in which CIRP can link the early, innate immune
response to sepsis with late-stage anergy. Although we did not
examine it in this study, another subset of regulatory T cells,
CD4+CD69+CD25- T cells, has been shown to be involved in
regulating immunosuppression in solid tumor mouse models
and in patients with leukemia relapse after allogeneic hematopoietic cell transplantation.38,39 These T cells do not express
Foxp3, but express membrane-bound TGF-β1, which mediates
suppression of T-cell proliferation.38 Whether CD4+CD69+
CD25- T cells play a role in sepsis needs further investigation.
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Figure 7 Increased gene expression in CD8+ T cells after treatment with rmCIRP. Puriﬁed splenic CD8+ T cells (1 × 106/ml/well) were
treated with rmCIRP (1 μg/ml) or PBS for 20 h during plate-bound anti-CD3/CD28 (1 μg/ml each) stimulation. Fold increase in expression
of granzyme B (a), RANTES (b) and IFN-γ (c) mRNA is shown relative to cells treated with PBS. β-actin was used as the reference gene.
Data expressed as mean ± s.e.m. (n = 4 per group) and compared by Student’s t-test. *Po0.05 vs PBS. rmCIRP, recombinant murine
CIRP; PBS, phosphate-buffered solution.

In this study, we have identiﬁed that CIRP activates T cells
through a TLR4-dependent mechanism. TLR4 is a cell-surface
receptor capable of identifying a diverse array of pathogenic
ligands; its activation leads to a complex signal transduction
pathway that results in the induction of expression of proinﬂammatory cytokines.40 Our ﬁndings are consistent with
previously reported data on the role of TLR4 in CIRPinduced cytokine release from macrophages.10 The presence
of TLR4 on T cells is well-established,41–43 and CIRP may exert
its effect on these cells directly or through other TLR4expressing cells. We have also shown an increase of CIRP
levels in the spleen after CLP. CIRP is widely expressed in
various cell types. Whether extracellular CIRP is released from
the spleen or inﬁltrates from sites of infection to stimulate
splenic T cells in sepsis requires further study.
In addition to identifying CIRP’s effects on T-cell activation,
we further determined the role of CIRP in CD4+ and CD8+
T-cell polarization. In CIRP-treated CD4+ T cells, there was an
increase in the expression of seven out of 84 genes in a Th1/
Th2 PCR array. Four of these genes, including Tbx21, Ifng,
Il12rb2 and Csf2, were associated with the Th1, or hyperinﬂammatory, response proﬁle. Tbx21 is the gene encoding
T-box transcription factor 21 or T-bet, which is a Th1speciﬁc transcription factor that controls expression of the
classic Th1 cytokine interferon-gamma (IFN-γ).44 Ifng is the
gene that encodes IFN-γ itself; its main sources are NK and
NKT cells, in addition to Th1 CD4+ T cells and cytotoxic CD8+
T cells.45 Il12rb2 codes for a subunit of the interleukin
12 receptor, a type I transmembrane protein whose inducible
expression is driven by T-bet. IL-12 signaling through this
receptor leads to the phosophorylation of STAT4, which acts
synergistically with T-bet to stimulate IFN-γ expression and
promote Th1 differentiation and proper function.46 Csf2
encodes colony stimulating factor 2, also known as granulocyte
macrophage-colony stimulating factor, which has been shown
to be required in order for mice to mount a Th1 response to
infection.47 These results demonstrate a propensity for CD4+
T cells to differentiate toward a hyperinﬂammatory Th1
response proﬁle in the presence of CIRP. Previous studies

have demonstrated the important role of TLR4 in skewing
immune responses toward a Th1 proﬁle.48,49 This is consistent
with our ﬁndings demonstrating the role of TLR4 in mediating
CIRP-induced T-cell activation, and the skewing of CIRPtreated cells towards a Th1 proﬁle.
CIRP-treated CD8+ T cells demonstrated increased expression
of three genes involved in cytotoxic T-cell responses: Gzmb, Ccl5
and Ifng. Gzmb encodes granzyme B, a serine protease that
mimics the caspases in its ability to cleave target cell proteins
after selected aspartate residues, making it the most powerful
proapoptotic granzyme.50 It acts in concert with perforin to
enter the cytosol of target cells and induce apoptosis. Its
upregulation in CIRP-treated CD8+ T cells is suggestive of a
cytotoxic proﬁle in these cells. Ccl5 encodes RANTES, a
proinﬂammatory chemokine degranulated from activated
CD8+ T cells, which can lead to further activation of T cells as
well as monocytes and neutrophils.51 IFN-γ, as discussed above,
is an important inﬂammatory cytokine primarily produced from
NK, NKT, Th1 CD4+ T cells and cytotoxic CD8+ T cells.
RANTES and IFN-γ were upregulated in CD8+ T cells after
CIRP treatment, although not to a signiﬁcant degree, in our
sample. Due to the variation of data among the tested samples,
the fold change in expression of these two genes does not
demonstrate statistical signiﬁcance by the Student’s t-test. This
suggests that subpopulations within the isolated splenic CD8+
T cells may have differential responses to rmCIRP.
SUMMARY
CIRP, a cold-shock protein recently discovered to act as a
DAMP in sepsis, promotes splenic CD4+ and CD8+ T-cell
activation in mice. CIRP-induced T-cell activation is mediated
by TLR4 and leads to upregulation of proinﬂammatory gene
expression in both CD4+ and CD8+ T cells. Our ﬁndings
demonstrate an important role of CIRP in mediating T-cell
dysfunction during sepsis.
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